• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎患者葡萄糖不耐受的机制:对治疗的影响。

Mechanisms of glucose intolerance in patients with chronic hepatitis C: implications for treatment.

机构信息

University Hospitals of Cleveland, Case Medical Center, Division of Gastroenterology and Hepatology, WRN5466, 11100 Euclid Avenue, Cleveland, OH 44106-5066, USA.

出版信息

Curr Infect Dis Rep. 2007 Mar;9(2):110-5. doi: 10.1007/s11908-007-0005-4.

DOI:10.1007/s11908-007-0005-4
PMID:17324347
Abstract

Both diabetes and chronic hepatitis C virus (HCV) infection are common conditions that often coexist in the same subject. Studies seem to confirm the presence of an association between them. Mechanisms leading to HCV-induced insulin resistance and glucose intolerance are beginning to be elucidated. Insulin resistance in the setting of chronic HCV infection could be related etiologically to viral factors but is also often seen with concomitant nonalcoholic fatty liver disease, the hepatic manifestation of the metabolic syndrome. Insulin resistance decreases the likelihood of response to interferon-based therapies and may be an independent risk factor for the progression of HCV-related liver disease.

摘要

糖尿病和慢性丙型肝炎病毒(HCV)感染都是常见的疾病,常常在同一患者中同时存在。研究似乎证实了两者之间存在关联。导致 HCV 引起的胰岛素抵抗和葡萄糖耐量受损的机制开始被阐明。在慢性 HCV 感染的情况下,胰岛素抵抗可能与病毒因素有关,但也经常与同时存在的非酒精性脂肪性肝病(代谢综合征的肝脏表现)有关。胰岛素抵抗降低了对基于干扰素的治疗的反应可能性,并且可能是 HCV 相关肝病进展的独立危险因素。

相似文献

1
Mechanisms of glucose intolerance in patients with chronic hepatitis C: implications for treatment.慢性丙型肝炎患者葡萄糖不耐受的机制:对治疗的影响。
Curr Infect Dis Rep. 2007 Mar;9(2):110-5. doi: 10.1007/s11908-007-0005-4.
2
Systematic review: chronic viral hepatitis and metabolic derangement.系统评价:慢性病毒性肝炎与代谢紊乱
Aliment Pharmacol Ther. 2020 Jan;51(2):216-230. doi: 10.1111/apt.15575. Epub 2019 Nov 20.
3
Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.丙型肝炎作为一种代谢性疾病:对 NASH 发病机制的影响。
Hepatol Res. 2005 Oct;33(2):145-50. doi: 10.1016/j.hepres.2005.09.023. Epub 2005 Oct 3.
4
Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection.与慢性丙型肝炎病毒感染相关的代谢表现及并发症
Gastroenterol Hepatol (N Y). 2016 May;12(5):293-9.
5
Hepatitis C and metabolic syndrome.丙型肝炎与代谢综合征
Expert Rev Endocrinol Metab. 2010 Mar;5(2):209-215. doi: 10.1586/eem.10.7.
6
Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.代谢综合征、非酒精性脂肪性肝病与慢性丙型肝炎的相互作用
Expert Rev Gastroenterol Hepatol. 2008 Apr;2(2):207-15. doi: 10.1586/17474124.2.2.207.
7
The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.代谢调节剂 PGC-1α 将丙型肝炎病毒感染与肝胰岛素抵抗联系起来。
J Hepatol. 2012 Oct;57(4):867-73. doi: 10.1016/j.jhep.2012.06.021. Epub 2012 Jun 23.
8
[Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].[丙型肝炎病毒相关性脂肪变性与代谢性脂肪变性。不同的疾病还是重叠的疾病?]
Ann Ital Med Int. 2005 Jan-Mar;20(1):10-22.
9
Non-alcoholic fatty liver disease and hepatitis C infection.非酒精性脂肪性肝病与丙型肝炎感染
Minerva Gastroenterol Dietol. 2006 Jun;52(2):135-43.
10
Hepatitis C Virus, Insulin Resistance, and Steatosis.丙型肝炎病毒、胰岛素抵抗与脂肪变性。
J Clin Transl Hepatol. 2016 Mar 28;4(1):66-75. doi: 10.14218/JCTH.2015.00051. Epub 2016 Mar 15.

本文引用的文献

1
Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.苯扎贝特对慢性丙型肝炎病毒感染患者的影响:与干扰素和利巴韦林联合使用。
J Viral Hepat. 2006 Jul;13(7):441-8. doi: 10.1111/j.1365-2893.2005.00718.x.
2
Impact of obesity on treatment of chronic hepatitis C.肥胖对慢性丙型肝炎治疗的影响。
Hepatology. 2006 Jun;43(6):1177-86. doi: 10.1002/hep.21239.
3
Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study.
丙型肝炎患者的促炎细胞因子、胰岛素抵抗和胰岛素分泌:一项病例对照研究。
Diabetes Care. 2006 May;29(5):1096-101. doi: 10.2337/diacare.2951096.
4
Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.在基因型1慢性丙型肝炎的非糖尿病患者中,胰岛素抵抗与脂肪变性相关。
Hepatology. 2006 Jan;43(1):64-71. doi: 10.1002/hep.20983.
5
Oxidative stress and hepatitis C viral infection.氧化应激与丙型肝炎病毒感染。
Hepatol Res. 2006 Feb;34(2):65-73. doi: 10.1016/j.hepres.2005.11.001. Epub 2005 Dec 20.
6
Steatosis in chronic hepatitis C: why does it really matter?慢性丙型肝炎中的脂肪变性:为何它确实重要?
Gut. 2006 Jan;55(1):123-30. doi: 10.1136/gut.2005.069757.
7
Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.在丙型肝炎病毒基因1型慢性肝炎患者中,对抗病毒治疗无反应与肥胖以及细胞因子信号转导抑制因子3(SOCS-3)的肝脏表达增加有关。
Gut. 2006 Apr;55(4):529-35. doi: 10.1136/gut.2005.069674. Epub 2005 Nov 18.
8
Hepatitis C virus infection can present with metabolic disease by inducing insulin resistance.丙型肝炎病毒感染可通过诱导胰岛素抵抗而引发代谢性疾病。
Intervirology. 2006;49(1-2):51-7. doi: 10.1159/000087263.
9
TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.肿瘤坏死因子α(TNFα)基因型影响丙型肝炎病毒(HCV)慢性肝炎中TNFα的释放、胰岛素敏感性及肝脏疾病的严重程度。
J Hepatol. 2005 Dec;43(6):944-50. doi: 10.1016/j.jhep.2005.05.035. Epub 2005 Jul 5.
10
Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy.胰岛素抵抗在慢性丙型肝炎的肝纤维化及对抗病毒治疗的反应中起重要作用。
Am J Gastroenterol. 2005 Jul;100(7):1509-15. doi: 10.1111/j.1572-0241.2005.41403.x.